Literature DB >> 18652793

Delirium: where do we stand?

Chi-Un Pae1, David M Marks, Changsu Han, Ashwin A Patkar, Prakash Masand.   

Abstract

Clinicians are likely to encounter delirium frequently, particularly in inpatient and intensive care settings. However, delirium is underrecognized and undertreated because of its heterogeneous and fluctuating presentation and due to the limitations in resources and training in contemporary clinical settings. Translation of current knowledge about delirium into clinical practice may improve patient care and benefit public health economics. Hence, this review comprehensively discusses the phenomenology and pathophysiology of delirium and its presenting features, risk factors, differential diagnoses, assessment, prognosis, and treatment with antipsychotics; the goal is to facilitate better prevention, recognition, and treatment of delirium. Available research is reviewed, limitations of the research are discussed, and future directions for further delirium research are identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18652793     DOI: 10.1007/s11920-008-0040-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  76 in total

Review 1.  Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine.

Authors:  P T Trzepacz
Journal:  Semin Clin Neuropsychiatry       Date:  2000-04

Review 2.  Delirium in the hospitalized elder and recommendations for practice.

Authors:  Ted S Rigney
Journal:  Geriatr Nurs       Date:  2006 May-Jun       Impact factor: 2.361

3.  A symptom rating scale for delirium.

Authors:  P T Trzepacz; R W Baker; J Greenhouse
Journal:  Psychiatry Res       Date:  1988-01       Impact factor: 3.222

Review 4.  Prevention, diagnosis and treatment of delirium: staff educational approaches.

Authors:  Naji Tabet; Robert Howard
Journal:  Expert Rev Neurother       Date:  2006-05       Impact factor: 4.618

Review 5.  Delirium.

Authors:  Ondria C Gleason
Journal:  Am Fam Physician       Date:  2003-03-01       Impact factor: 3.292

Review 6.  The measurement of delirium: review of scales.

Authors:  Marieke J Schuurmans; Patricia I Deschamps; Susan W Markham; Lillie M Shortridge-Baggett; Sijmen A Duursma
Journal:  Res Theory Nurs Pract       Date:  2003       Impact factor: 0.688

Review 7.  Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment.

Authors:  A Britton; R Russell
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  The Delirium Observation Screening Scale: a screening instrument for delirium.

Authors:  Marieke J Schuurmans; Lillie M Shortridge-Baggett; Sijmen A Duursma
Journal:  Res Theory Nurs Pract       Date:  2003       Impact factor: 0.688

Review 9.  Risk factors for intensive care delirium: a systematic review.

Authors:  Bart Van Rompaey; Marieke J Schuurmans; Lillie M Shortridge-Baggett; Steven Truijen; Leo Bossaert
Journal:  Intensive Crit Care Nurs       Date:  2007-10-18       Impact factor: 3.072

Review 10.  The importance of diagnosing and managing ICU delirium.

Authors:  Brenda T Pun; E Wesley Ely
Journal:  Chest       Date:  2007-08       Impact factor: 9.410

View more
  3 in total

Review 1.  Delirium: sifting through the confusion.

Authors:  Raheel A Khan; Debra Kahn; James A Bourgeois
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

2.  Delirium and antipsychotics: a systematic review of epidemiology and somatic treatment options.

Authors:  Joseph D Markowitz; Meera Narasimhan
Journal:  Psychiatry (Edgmont)       Date:  2008-10

3.  Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.

Authors:  Hyung-Jun Yoon; Kyoung-Min Park; Won-Jung Choi; Soo-Hee Choi; Jin-Young Park; Jae-Jin Kim; Jeong-Ho Seok
Journal:  BMC Psychiatry       Date:  2013-09-30       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.